EGFR and central nervous system cancer: Ongoing clinical trials for fluorescence guided surgery of brain tumors using EGFR antibody or affibody (NCT03510208, NCT02901925 and NCT04085887) indicate the active exploration of molecular targeting strategy for detecting gliomas in both adults and children.